Also trades as: 0R0H.L (LSE) · $vol 6M · TMO.NE (NEO) · $vol 0M · TN8.DE (XETRA) · $vol 0M

$448.28

-1.09 (-0.24%)

Weekly Expected Move ±5.6%

$389 $414 $438 $463 $487

NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Strong Sell · Power 37 · $166.6B mcap · 371M float · 0.579% daily turnover · Short 31% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$44.6B +3.9% ▲

5Y CAGR: +6.7%

Gross Profit

$16.8B -5.4% ▼

5Y CAGR: +0.9%

Operating Income

$8.1B +5.8% ▲

5Y CAGR: +0.5%

Net Income

$6.7B +6.3% ▲

5Y CAGR: +1.1%

EPS (Diluted)

$17.74 +7.3% ▲

5Y CAGR: +2.1%

EBITDA

$11.5B -2.8% ▼

5Y CAGR: +2.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$39.2B	$44.9B	$42.9B	$42.9B	$44.6B
YoY Growth	+21.7%	+14.5%	-4.6%	+0.1%	+3.9%
Cost of Revenue	$19.6B	$25.9B	$25.7B	$25.2B	$27.8B
Gross Profit	$19.6B	$19.0B	$17.2B	$17.7B	$16.8B
Gross Margin	50.1%	42.3%	40.1%	41.3%	37.7%
R&D Expenses	$1.4B	$1.5B	$1.3B	$1.4B	$1.4B
SG&A Expenses	$7.9B	$9.0B	$8.4B	$8.7B	$7.3B
Operating Expenses	$9.3B	$10.5B	$9.7B	$10.1B	$8.7B
Operating Income	$10.3B	$8.5B	$7.4B	$7.7B	$8.1B
Operating Margin	26.3%	19.0%	17.4%	17.9%	18.2%
Interest Expense	$536M	$726M	$1.5B	$1.7B	$1.4B
Income Before Tax	$8.8B	$7.7B	$6.2B	$7.0B	$7.3B
Tax Expense	$1.1B	$703M	$284M	$657M	$547M
Net Income	$7.7B	$7.0B	$6.0B	$6.3B	$6.7B
Net Margin	19.7%	15.5%	14.0%	14.8%	15.1%
EPS (Diluted)	$19.46	$17.64	$15.45	$16.53	$17.74
EBITDA	$12.0B	$11.9B	$11.2B	$11.8B	$11.5B
Shares Outstanding	397M	394M	388M	383M	377M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$10.5B	$10.6B	$11.4B	$10.4B	$10.9B	$11.1B	$12.2B	$11.0B
Cost of Revenue	$6.2B	$6.3B	$6.9B	$6.1B	$6.8B	$6.5B	$7.6B	$6.5B
Gross Profit	$4.3B	$4.3B	$4.5B	$4.2B	$4.0B	$4.7B	$4.6B	$4.5B
Gross Margin	41.2%	41.0%	39.2%	41.0%	37.3%	41.8%	38.0%	40.7%
R&D Expenses	$339M	$346M	$374M	$342M	$352M	$347M	$357M	$336M
SG&A Expenses	$2.2B	$2.1B	$1.8B	$2.1B	$1.8B	$2.4B	$2.0B	$1.8B
Operating Expenses	$2.6B	$2.4B	$2.2B	$2.4B	$2.1B	$2.7B	$2.3B	$2.6B
Operating Income	$1.8B	$1.9B	$2.3B	$1.8B	$1.9B	$1.9B	$2.3B	$1.9B
Operating Margin	16.7%	18.1%	19.9%	17.8%	17.7%	17.5%	18.8%	16.9%
Interest Expense	$421M	$424M	$384M	$303M	$404M	$347M	$365M	$354M
Income Before Tax	$1.7B	$1.7B	$2.0B	$1.6B	$1.7B	$1.8B	$2.1B	$1.7B
Tax Expense	$128M	$99M	$150M	$95M	$92M	$207M	$153M	$70M
Net Income	$1.5B	$1.6B	$1.8B	$1.5B	$1.6B	$1.6B	$2.0B	$1.7B
Net Margin	14.7%	15.4%	16.1%	14.5%	14.9%	14.5%	16.2%	15.0%
EPS (Diluted)	$4.04	$4.24	$4.78	$3.98	$4.28	$4.27	$5.21	$4.43
EBITDA	$3.0B	$2.9B	$3.1B	$2.6B	$2.8B	$2.8B	$3.2B	$2.3B
Shares Outstanding	383M	384M	383M	379M	378M	378M	377M	373M

TMO NYSE